Events – Clinical Value of Diagnostics https://clinicalvalue.com/en-au/ Wed, 20 Nov 2024 05:46:36 +0000 en-AU hourly 1 https://wordpress.org/?v=6.6.2 https://i0.wp.com/clinicalvalue.com/wp-content/uploads/2023/01/apple-touch-icon.png?fit=32%2C32&ssl=1 Events – Clinical Value of Diagnostics https://clinicalvalue.com/en-au/ 32 32 225041835 APAC Oncology Summit 2024 Webinar https://clinicalvalue.com/en-au/event/apac-oncology-summit-2024-webinar/ Fri, 20 Sep 2024 05:00:50 +0000 https://clinicalvalue.com/event/apac-oncology-summit-2024-webinar/ ...

The post APAC Oncology Summit 2024 Webinar appeared first on Clinical Value of Diagnostics.

]]>
2024 APAC Onco Summit header image
Supported by:
APAC Oncology summit APODDC
atorglogo
Singapore Society of Oncology logo
Join us for an insightful webinar discussion on the use of precision oncology and breast cancer management in the Asia-Pacific (APAC) region. This event will feature leading oncologists who will share their clinical expertise and discuss the application of Comprehensive Genomic Profiling (CGP) and Molecular Tumor Board (MTB), as well as updated breast cancer testing and treatment in APAC region:

Details

Time

16:00 - 19:30

Topics

Clinical sharing on the effective role of comprehensive genomic profiling (CGP) within molecular tumour boards (MTBs) in clinical settings

Latest developments in liquid biopsy and associated approaches in cancer care

The clinical utility of CGP across tumour types and the value of precision oncology to improve patient outcomes

Value of PIK3CA mutation testing in HR+/HER2- metastatic breast cancer

Register for the webinar now! We look forward to seeing you there!

You might want to join us if you are a:

  • Medical oncologist
  • Molecular Pathologist
  • Medical Technologist
  • Bioinformatician
  • Geneticist

Key reasons to attend:

  • Hear from experts on their clinical experience using CGP, MTB, and their value in precision oncology
  • Get updates on the new biomarker and genomic signatures, and tissue-based vs liquid-based testing
  • Learn about upcoming PIK3CA testing and treatment in breast cancer

Speakers

Herbert Loong Portrait modified

Dr. Herbert Loong

Deputy Medical Director,
Phase 1 Clinical Trials Centre,
The Chinese University of Hong Kong
Dr Linda Mileshkin modified

Dr. Linda Mileshkin

Director of Medical Oncology,
Peter MacCallum Cancer Centre, Australia
Screenshot 2024 08 30 145608 modified

Dr. Sewanti Limaye

Director of Medical & Precision Oncology,
Reliance Foundation Hospital & Research Center, India
Dr Dejan Juric modified

Dr. Dejan Juric

Director,
Termeer Center for Targeted Therapies & Investigational Cancer Therapeutics Program,
Massachusetts General Hospital Cancer Centre, U.S.A.

Moderators

ICC SGP Doctor Pics for Website DanielChan 1 modified

Dr. Daniel Chan

Senior Consultant,
Medical Oncology,
ICON Cancer Centre, Singapore
yap yoon sim portrait modified

Dr. Yoon Sim Yap

Senior Consultant,
Division of Medical Oncology,
National Cancer Centre, Singapore

Agenda

Time

Topic

Speakers

16:00 - 16:10
Opening and Introduction
Mr. Lance Little
Head of Region Asia Pacific,
Roche Diagnostics Ltd.
16:10 - 16:40
Trends and Challenges in Molecular Tumour Board Implementation in Asia-Pacific Region: APAC MTB Expert Consensus Statement
Dr. Herbert Loong
16:40 - 17:10
Unlocking the Power of Liquid Biopsy-based Profiling in Clinical Practice
Dr. Linda Mileshkin
17:10 - 17:40
Panel Discussion: Facilitating Access to Molecularly Guided Treatment Options by Leveraging Advancements in Genomic Profiling and Molecular Tumour Boards
Panelists:
Dr. Herbert Loong
Dr. Linda Mileshkin
Dr. Aya Helali
17:40 - 17:55
Break
All
17:55 - 18:25
The Evolution of Comprehensive Genomic Profiling: From Lung Cancer Pioneers to Ovarian and Breast Cancer Paradigms
Dr. Sewanti Limaye
18:25 - 18:55
Targeting PIK3CA Mutation in Breast Cancer: From Testing to Therapeutic Strategies
Dr. Dejan Juric
18:55 - 19:25
Panel Discussion: Management of Novel Genes in Breast Cancer
Panelists:
Dr. Dejan Juric
Dr. Sewanti Limaye
Dr. Pranav Dorwal
19:25 - 19:30
Closing
Dr. Ahmed Elhusseiny
Area Head APAC,
Roche Pharmaceuticals
APAC remote pathology calen

Date:

5 thDecember 2024
APAC remote pathology assets5 time

Time:
16:00 - 19:30 (GMT+08:00)
13:00 - 16:30(Karachi)
13:30 - 17:00(Delhi)
15:00 - 18:30 (Bangkok / Ho Chi Minh / Jakarta)
16:00 - 19:30 (Hong Kong / Kuala Lumpur / Singapore)
17:00 - 20:30(Seoul / Tokyo)
19:00 - 22:30(Melbourne)
20:00 - 23:30(New Zealand)

This material represents personal viewpoint and is intended to promote the communication and exchange of medical information, and shall be used by healthcare professionals as a reference only. This material may contain medicinal products or clinical indications that have not yet been approved in your country. Please refer to the locally approved package insert for detailed prescription information.

The post APAC Oncology Summit 2024 Webinar appeared first on Clinical Value of Diagnostics.

]]> 9120